Global Helium-free Magnetocardiograph Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Helium-free Magnetocardiograph market size was valued at US$ 18.63 million in 2025 and is forecast to a readjusted size of US$ 29.58 million by 2032 with a CAGR of 7.6% during review period.
Liquid helium free magnetocardiography (non superconducting magnetocardiography) is a high-end diagnostic device based on room temperature magnetic sensing technology for non-invasive detection of weak magnetic fields in the heart. It usually uses an optical pump magnetometer or other high-sensitivity room temperature magnetic sensing solutions. Compared with superconducting systems, it does not require low-temperature cooling and complex shielding, and has more friendly installation and operation conditions, making it more suitable for clinical promotion and application. Based on existing data, the global sales volume is estimated to be around 23 units in 2025, with an average unit price of approximately $787000. Due to the complexity of system integration and the supply of core sensors, the overall industry capacity utilization rate is approximately 68%. Upstream enterprises are mainly distributed in the fields of high-sensitivity room temperature magnetic sensors, precision optical devices, low-noise electronic and signal processing chips, magnetic shielding materials, etc., while downstream enterprises are concentrated in the fields of medical equipment manufacturing, clinical system integration, and hospital delivery services, with an overall gross profit margin of about 35% to 48%. In the product cost structure, core magnetic sensors and optical systems account for about 40% of the total cost, electronic and algorithm hardware account for about 20%, system integration and assembly account for about 20%, research and development testing accounts for about 10%, and sales and after-sales service account for about 10%. According to parameters and configurations, non superconducting magnetocardiography can be classified into fixed and semi mobile systems, as well as different configuration versions for scientific research and clinical screening. In terms of demand, the downstream demand list includes early screening for arrhythmia and cardiomyopathy in large hospitals, monitoring of cardiac function in newborns and children, evaluation of cardiac inflammation and drug cardiac safety, construction of regional cardiovascular diagnosis and treatment centers, and research on biomagnetism in universities and research institutions; The downstream customer list mainly includes cardiology departments of tertiary hospitals, specialized cardiac hospitals, medical research institutes, and high-end physical examination and functional medicine centers. In terms of business opportunities, policy drivers are reflected in the continuous strengthening of early diagnosis and screening of cardiovascular diseases and support for the localization of high-end medical equipment. Technological innovation drivers are focused on improving the sensitivity of room temperature magnetic sensing, the maturity of multi-channel array algorithms and artificial intelligence assisted interpretation, and changes in consumer demands are reflected in the significant increase in clinical attention to non-invasive testing, controllable operation and maintenance costs, and higher cost-effectiveness solutions. These factors together promote non superconducting magnetocardiography to become the most important incremental direction in the magnetocardiography market in the coming years.
The absence of liquid helium magnetocardiography represents an important direction for the evolution of the magnetocardiography industry towards scalable clinical applications. Its core value lies in completely eliminating the dependence on liquid helium, significantly reducing operational complexity and long-term usage costs, and enabling magnetocardiography to move from a few research centers to more clinical scenarios. The current market is still in the stage of introduction and verification, with installations mainly concentrated in technologically advanced cardiac specialty hospitals and research institutions. However, with the improvement of room temperature magnetic sensor sensitivity, mature low-noise algorithms, and advances in system level magnetic shielding and compensation technology, the liquid helium free solution is rapidly approaching traditional superconducting systems in terms of clinical availability and stability. From the demand side, hospitals place significantly higher emphasis on equipment reliability, continuous operation capability, and full lifecycle cost than on extreme sensitivity, making liquid helium free magnetocardiography more attractive in medical institutions with budget constraints but pursuing advanced diagnostic capabilities. In the medium to long term, the support of policies for the localization and green low-carbon operation of high-end medical equipment, the evolution of technological routes towards standardization and modularization, and the continuous growth of patients' demand for non-invasive and precise cardiac testing will jointly promote the steady increase in the market share of liquid helium free magnetocardiography, becoming a key breakthrough for the magnetocardiography industry to move from a high barrier niche market to a sustainable and high-volume market.
This report is a detailed and comprehensive analysis for global Helium-free Magnetocardiograph market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Helium-free Magnetocardiograph market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Helium-free Magnetocardiograph market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Helium-free Magnetocardiograph market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Helium-free Magnetocardiograph market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Helium-free Magnetocardiograph
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Helium-free Magnetocardiograph market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Beijing X-Magtech Technologies, Genetesis, Hangzhou Nuochi Life Science, Hangzhou Chinmag Technology, SandboxAQ, Hangzhou Lingci Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Helium-free Magnetocardiograph market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Coil Magnetocardiography Magnetocardiography System
Magnetic Reluctance Magnetocardiography System
Atomic Magnetometer Magnetocardiography System
Market segment by Open or Closed
Fully Enclosed Type
Semi-Open Type
Open-Ended Type
Market segment by Channels
32 Channel Type
64 Channel Type
96 Channel Type
Other
Market segment by Application
Medical
Research and Education
Major players covered
Beijing X-Magtech Technologies
Genetesis
Hangzhou Nuochi Life Science
Hangzhou Chinmag Technology
SandboxAQ
Hangzhou Lingci Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Helium-free Magnetocardiograph product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Helium-free Magnetocardiograph, with price, sales quantity, revenue, and global market share of Helium-free Magnetocardiograph from 2021 to 2026.
Chapter 3, the Helium-free Magnetocardiograph competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Helium-free Magnetocardiograph breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Helium-free Magnetocardiograph market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Helium-free Magnetocardiograph.
Chapter 14 and 15, to describe Helium-free Magnetocardiograph sales channel, distributors, customers, research findings and conclusion.